Basel Medical Group Ltd [NASDAQ: BMGL] closed the trading session at $3.06 on 2025-07-14.
If compared to the average trading volume of 7.23M shares, BMGL reached to a volume of 32602193 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Basel Medical Group Ltd [BMGL]:
The Price to Book ratio for the last quarter was 10.78, with the Price to Cash per share for the same quarter was set at 0.29.
BMGL stock trade performance evaluation
Basel Medical Group Ltd [BMGL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 59.38.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BMGL stock in for the last two-week period is set at 53.23, with the RSI for the last a single of trading hit 0.86, and the three-weeks RSI is set at 0.83 for Basel Medical Group Ltd [BMGL]. The present Moving Average for the last 50 days of trading for this stock 3.03, while it was recorded at 2.74 for the last single week of trading.
Basel Medical Group Ltd [BMGL]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Basel Medical Group Ltd [BMGL] shares currently have an operating margin of -2.81% and a Gross Margin at 22.84%. Basel Medical Group Ltd’s Net Margin is presently recorded at 4.21%.
Return on Equity for this stock inclined to 2.67%, with Return on Assets sitting at 2.67%.
